• Beam Therapeutics (NASDAQ:BEAM) Earns Buy Rating from HC Wainwright

    Source: Buzz FX / 11 Mar 2025 12:41:16   America/Chicago


    Beam Therapeutics (NASDAQ:BEAM) Earns Buy Rating from HC Wainwright Written by MarketBeat March 11, 2025 Share Link copied to clipboard. Remove Ads Beam Therapeutics ( NASDAQ:BEAM - Get Free Report ) 's stock had its "buy" rating reissued b
    Read more...
Share on,